Sustained effect of macitentan, a novel oral endothelin receptor antagonist, on exercise capacity and the association of its measure with long-term outcomes in pulmonary arterial hypertension
- Resource Type
- Journal
- Source
EUROPEAN HEART JOURNAL ; AUG 2013, 34 p186-p186, 1p. Supplement: 1- Subject
- Language
- English
- ISSN
- 15229645